Shareef Nahas
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Cancer Genomics and Diagnostics
Papers in
-
- DNA Repair Mechanisms 21
- CRISPR and Genetic Engineering 5
- RNA and protein synthesis mechanisms 4
- Genetics 11
- Genomics and Rare Diseases 5
- Genetics and Neurodevelopmental Disorders 3
- Co-authors
- Richard A. Gatti (23 shared papers)Liutao Du (6 shared papers)David Dimmock (12 shared papers)Chih‐Hung Lai (4 shared papers)Stephen F. Kingsmore (12 shared papers)Shimul Chowdhury (9 shared papers)Helen H. Chun (3 shared papers)Nathaly M. Sweeney (4 shared papers)
- Journals
- Molecular Case Studies (6 papers)npj Genomic Medicine (3 papers)Neuromuscular Disorders (2 papers)Blood (2 papers)Human Mutation (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Shareef Nahas
43 papers receiving 1.8k citations
Shareef Nahas's Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 355
- Cancer Research 346
- Genetics 529
- Genetics 183
- Molecular Biology 943
Countries citing papers authored by Shareef Nahas
This map shows the geographic impact of Shareef Nahas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shareef Nahas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shareef Nahas more than expected).
Fields of papers citing papers by Shareef Nahas
This network shows the impact of papers produced by Shareef Nahas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shareef Nahas. The network helps show where Shareef Nahas may publish in the future.
Co-authors
The 25 scholars most cited alongside Shareef Nahas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization Hit paper breakdown → | 2018 | 284 |
| 2 | 2015 | 217 | |
| 3 | 2015 | 141 | |
| 4 | 2004 | 128 | |
| 5 | 2003 | 125 | |
| 6 | 2009 | 112 | |
| 7 | 2019 | 91 | |
| 8 | 2003 | 65 | |
| 9 | 2011 | 63 | |
| 10 | 2008 | 53 | |
| 11 | 2021 | 52 | |
| 12 | 2013 | 46 | |
| 13 | 2013 | 44 | |
| 14 | 2009 | 40 | |
| 15 | 2011 | 33 | |
| 16 | 2005 | 33 | |
| 17 | 2011 | 30 | |
| 18 | 2009 | 29 | |
| 19 | 2021 | 26 | |
| 20 | 2003 | 23 |
About Shareef Nahas
Shareef Nahas is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Hematology, having authored 43 papers that have together received 1.9k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (21 papers), Carcinogens and Genotoxicity Assessment (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer-related Molecular Pathways (5 papers), Genomics and Rare Diseases (5 papers), CRISPR and Genetic Engineering (5 papers), RNA and protein synthesis mechanisms (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). The work is most often cited by research in Hematology (355 citations), Cancer Research (346 citations), Genetics (529 citations), Genetics (183 citations) and Molecular Biology (943 citations). Shareef Nahas has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Richard A. Gatti, Liutao Du, David Dimmock, Chih‐Hung Lai, Stephen F. Kingsmore, Shimul Chowdhury, Helen H. Chun, Nathaly M. Sweeney, Hailiang Hu and Midori Mitui. Their work appears in journals such as Molecular Case Studies, npj Genomic Medicine, Neuromuscular Disorders, Blood and Human Mutation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.